Lilly and Mubadala Bio plan Abu Dhabi medicine packaging
The collaboration targets a 125,000-square-metre KEZAD site.
- Publish date: 2026-10-21
- Category: Standards & Policy
- Original source: Emirates News Agency (WAM)
- Reading time: 1 min read
Eli Lilly and Mubadala Bio announced plans for local packaging and logistics for Lilly GLP-1 medicines in Abu Dhabi. The proposed work would use a 125,000-square-metre KEZAD site with packaging and warehousing facilities, building pharmaceutical contract-manufacturing and logistics capacity for global partners.